Mark Greenwald to Drug Administration Schedule
This is a "connection" page, showing publications Mark Greenwald has written about Drug Administration Schedule.
Connection Strength
0.038
-
Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2019 02 23; 393(10173):778-790.
Score: 0.033
-
Are current pediatric dose recommendations for intravenous theophylline appropriate? J Asthma. 1993; 30(2):109-21.
Score: 0.005